How to Test Human-Specific Combination Immunotherapies In Vivo
Por um escritor misterioso
Descrição
Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
The NK-92 cell line—30 years later: its impact on natural killer cell research and treatment of cancer - Cytotherapy
Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy - Yang - 2023 - Advanced Science - Wiley Online Library
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy - ScienceDirect
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
In vivo gene immunotherapy for cancer
In vitro functional assays to augment immunotherapy research
Steps involved in establishing human immune system (HIS) models in
In vivo imaging of nanoparticle-labeled CAR T cells
Antibodies, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
